ONGOING drug shortages cost Britain's National Health Service (NHS) 38m (AU$66.2m) last month as more emergency price increases were agreed to boost stocks, according to an analysis by the Evidence-Based Medicine DataLab at the University of Oxford.
There were a record 91 emergency price rises agreed in November, as the NHS continued to experience supply problems that are estimated to have cost the service more than 200m since April 2017.
The above article was sent to subscribers in Pharmacy Daily's issue from 22 Dec 17
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 22 Dec 17
